For the first time, the EAN headquarters in Vienna has been awarded the Workplace Health Promotion seal of approval by the Austrian health fund.

Application open now for this postgraduate course the 2026-2027 academic year. Deadline: 15 May.

We are delighted to invite you to take part in the EAN Regional Teaching Day in Yerevan, Armenia, on 22 May 2026.

Our summary of neurological news items the European Medicines Agency (EMA) monthly Human Medicines Newsletter.

A review of the now-completed ENERGY project, established to provide robust epidemiological data on neurological manifestations in patients with COVID-19.

Harvard-trained neuroanatomist and bestselling author Jill Bolte Taylor delivers a fascinating plenary lecture at the 2026 European Congress of Radiology.

The EAN will once again be offering a wide range of hands-on courses at the EAN Congress 2026 in Geneva, as well as the successfully introduced e-hands-on courses.

Event marks major milestone in EAN’s strategic efforts to shape the future of neurology and strengthen collaboration at both European and national levels.

Collaborative statement highlights urgent need to keep palliative care at the heart of support for those living with long-term neurological conditions and entering end-of-life care.

eanNews Editor, Benedetta Bodini, highlights some recent developments on the EAN's popular news platform

Each month the eanNews editorial team reviews the scientific press for recently published papers of outstanding interest to neurologists. Here we present our selection for April 2026.

Welcome to the April 2026 edition of the President’s Corner, our article series in which the EAN President, Elena Moro, answers your questions!

Newly elected Individual Delegates and nominated Institutional Delegates will start their term on 27 June 2026 in Geneva, Switzerland.

The European Journal of Neurology recognises its most active reviewers of 2025, offering an article processing charge waiver to those who reviewed five or more papers.

Results of the EMPHASIS study, evaluating the efficacy and safety of minocycline in addition to routine treatment in patients with acute ischaemic stroke.